<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The levels of c-myc protein expression in three types of Epstein-Barr virus (EBV) transformed human B-cell derived lines were examined with an ELISA assay </plain></SENT>
<SENT sid="1" pm="."><plain>Six independently maintained sublines of the same EBV-transformed pro-B-cell line (FLEB-14), six B-cell lines (LCL) and six Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> lines (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) were compared </plain></SENT>
<SENT sid="2" pm="."><plain>The average amount of c-myc protein, calculated from at least three independent tests on each line, differed between the three groups </plain></SENT>
<SENT sid="3" pm="."><plain>Expressed in relative units, the ratio of the means was 1:2:5 for the LCL:FLEB:<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> lines </plain></SENT>
<SENT sid="4" pm="."><plain>The differences were statistically significant at P less than 0.01 </plain></SENT>
</text></document>